Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
CachexiaNeoplasms
Interventions
OTHER

standard care

Routine oncology and palliative care

DIETARY_SUPPLEMENT

nutritional supplements and advice

n-3 PUFA enriched supplements, dietary advice

BEHAVIORAL

home-based self-assisted exercise program

Strength and aerobic

DRUG

Ibuprofen

400mgx3

Trial Locations (17)

CA 90048

Cedars-Sinai Medical Center, Los Angeles

Unknown

CA4 Brampton Civic Hospital, Brampton

Cross Cancer Insitute, Edmonton

Jewish General Hospital, Montreal

Ottawa Regional Cancer Centre, Ottawa

Universitätsklinikum Bonn, Bonn

Oslo University Hospital, Oslo

St Olavs Hospital, Trondheim

Tumor Zentrum, Aarau

Cantonal Hospital, Sankt Gallen

NHS Forth Valley, Larbert

Queen Margaret Hospital, Dunfermline

Llandough Hospital, Cardiff

Edinburgh Cancer Centre, Edinburgh

Beatson West of Scotland Cancer Centre, Glasgow

Chelsea and Westminister Hospital NHS, London

Guys and St Thomas, London

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

Cantonal Hospital of St. Gallen

OTHER

collaborator

Ottawa Regional Cancer Centre

OTHER

collaborator

Jewish General Hospital

OTHER

collaborator

Cross Cancer Institute

OTHER

collaborator

The Beatson West of Scotland Cancer Centre

UNKNOWN

collaborator

Queen Margaret Hospital, Dunfermline

OTHER

collaborator

Cancer Research UK Edinburgh Centre

UNKNOWN

collaborator

Malteser Krankenhaus Seliger Gerhardt

UNKNOWN

collaborator

Tumor Biology Center Freiburg

UNKNOWN

collaborator

Tumor Zentrum Aarau

UNKNOWN

collaborator

Chelsea and Westminster NHS Foundation Trust

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

NHS Forth Valley

OTHER_GOV

lead

Norwegian University of Science and Technology

OTHER

NCT02330926 - Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy | Biotech Hunter | Biotech Hunter